Editorial: Metabolomic profiling of cardiac substrate utilization fanning the flames of systems biology?

Circulation

Volumn 119, Issue 13, 2009, Pages 1700-1702

  Ashrafian, Houman ^a   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Editorials; Hypoxia; Metabolism; Reperfusion; Surgery

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; CARNITINE; DICHLOROACETIC ACID; FATTY ACID; GLUCOSE; GLUCOSE INSULIN POTASSIUM; GLUTAMIC ACID; KETONE; POTASSIUM DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

CITRIC ACID CYCLE; EDITORIAL; ENERGY METABOLISM; ENZYME SUBSTRATE; FATTY ACID OXIDATION; FUNDING; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART SURGERY; HEMODYNAMICS; HYPOXIA; METABOLOMICS; PRIORITY JOURNAL; REPERFUSION; HEART; HEART DISEASE; HEART MUSCLE; HUMAN; METABOLISM; METABOLOME; NOTE; PHYSIOLOGY; SYSTEMS BIOLOGY;

HEART; HEART DISEASES; HUMANS; METABOLOME; MYOCARDIUM; SYSTEMS BIOLOGY;

EID: 65349160988     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.849919     Document Type: Editorial

References (21)

1. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95:135-145.
2. Neubauer S. The failing heart: an engine out of fuel. N Engl J Med. 2007;356:1140-1151.
3. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116:434-448.
4. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
5. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart II: studies on fat, ketone and amino acid metabolism. Am J Med. 1954;16: 504-515.
6. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455:1054-1056.
7. Mayr M, Yusuf S, Weir G, Chung YL, Mayr U, Yin X, Ladroue C, Madhu B, Roberts N, De SA, Fredericks S, Stubbs M, Griffiths JR,Jahangiri M, Xu Q, Camm AJ. Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol. 2008;51: 585-594.
8. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005;112:3868-3875.
9. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, Shaham O, Berriz G, Lowry PA, Palacios IF, Tasan M, Roth FP, Min J, Baumgartner C, Keshishian H, Addona T, Mootha VK, Rosenzweig A, Carr SA, Fifer MA, Sabatine MS, Gerszten RE. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest. 2008;118:3503-3512.
10. Lewis GD, Asnani A, Gerszten RE. Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol. 2008;52:117-123.
11. Loscalzo J, Kohane I, Barabasi AL. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007;3:124-134.
12. Mayr M. Metabolomics: ready for the prime time? Circ Cardiovasc Genet. 2008;1:58 -65.
13. Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, Mathew JP, Schwinn DA, Glower DD, Newgard CB, Podgoreanu MV. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation. 2009;119:1736-1746.
14. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest. 1988;82:2017-2025.
15. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann NY Acad Sci. 2004;1015:202-213.
16. Lewandowski ED, White LT. Pyruvate dehydrogenase influences postis- chemic heart function. Circulation. 1995;91:2071-2079.
17. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004;70:309-319.
18. King LM, Sidell RJ, Wilding JR, Radda GK, Clarke K. Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia. Am J Physiol Heart Circ Physiol. 2001;280:H1173-H1181.
19. Sridharan V, Guichard J, Li CY, Muise-Helmericks R, Beeson CC, Wright GL. O(2)-sensing signal cascade: clamping of O(2) respiration, reduced ATP utilization, and inducible fumarate respiration. Am J Physiol Cell Physiol. 2008;295:C29-C37.
20. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honore JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapel le P, Di Polo A, Beausejour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14:1067-1076.
21. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, Wu TJ, Jin L, Liaw C, Chen R, Richman J, Connolly D, Offermanns S, Wright SD, Waters MG. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem. 2005;280:26649 -26652.